Immunoglobulin treatment of multiple sclerosis: Future prospects

Neurological Sciences

Volumn 24, Issue SUPPL. 4, 2003, Pages

  Durelli, L ^a   Ricci, A ^a   Verdun, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Encephalomyelitis; High dose; IgG; Multiple sclerosis; Pregnancy

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT DEPENDENT CYTOTOXICITY; DEMYELINATING DISEASE; DEMYELINATION; DRUG EFFICACY; DRUG MEGADOSE; ENCEPHALOMYELITIS; FEMALE; HEADACHE; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PUERPERIUM; RASH; RECURRENCE RISK; REMISSION;

DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; TIME FACTORS;

EID: 0142217514     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0085-3     Document Type: Article

References (19)

1. Fazekas F, Deisenhammer F, Strasser-Fuchs S et al (1997) Randomised placebo-controlled trial of montly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Lancet 349:589-593
2. Achiron A, Gabbay U, Gilad R et al (1998) Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology 50:398-402
3. Sorensen PS, Wanscher B, Jensen CV et al (1998) Intravenous immunoglobulin G reduces MRI activity in relapsing-remitting multiple sclerosis. Neurology 50:1273-1281
4. Soelberg-Sorensen P (2001) Communication during ESIMS investigator meeting, Venice, October 17
5. Noseworhty JH, O'Brien PC, Weinshenker BG et al (2000) HIVIgG does not reverse established weakness in MS: a double-blind, placebo-controlled trial. Neurology 54:1135-1143
6. Miller DJ, Rodriguez M (1995) A monoclonal autoAb that promotes central nervous system remyelination in a model of multiple sclerosis is a natural Ab encoded by germline immunoglobuli genes. J Immunol 154:2460-2469
7. Lucchinetti C, Bruch W, Parisi J, Sheithauer B, Rodriguez M, Lassmann H (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. Brain 122(12):2279-2295
8. Lucchinetti C, Bruch W, Parisi J, Sheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717
9. Weinshenker BG et al (1999) A Randomized Trial of Plasma Exchange in Acute Central Nervous System Inflammatory Demyelinating Disease. Ann Neurol 46:878-886
10. Hahn JS et al (1996) Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 46:1173-1174
11. Pradhan S et al (1999) Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Neurol Sci 165:56-61
12. Sahlas DJ et al (2000) Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 54:1370-1372
13. Nos C et al (1996) High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis. J Neurol Neurosurg Psychiatry 61: 418 - 429
14. Jacobs LD, Beck RW, Simon JH et al (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343:898-904
15. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O, Hartung HP, Seeldrayers P, Soelberg-Sorensen P, Rovaris M, Martinelli F, Martinelli V, Rodegher M, Francis G, Hommes OR (2001) ETOMS study group Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357:1576-1582
16. Confavreux C et al (1998) Rate of pregnancy-related relapses in multiple sclerosis. N Engl J Med 339(5):285-291
17. Achiron A, Rotstein Z, Noy S, Mashiach S, Dulitzky M, Achiron R (1996) Intravenous immunoglobulin treatment in the prevention of childbirth associated acute in multiple sclerosis - A pilot study. J Neurol 243:25-28
18. Orvieto R, Achiron R, Rotstein Z, Noy S, Bar-Hava I, Achiron A (1999) Pregnancy and multiple sclerosis: a 2 year experience. Eur J Obstet & Gynecol Reprod Biol 82:191-194
19. Haas J (2000) High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler 5[Suppl 2]:S18-S20